RecruitingNot applicableNCT00358943
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Studying Gaucher disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Genzyme, a Sanofi Company
- Principal Investigator
- Study DirectorGenzyme, a Sanofi Company
- Enrollment
- 12000 enrolled
- Eligibility
- All sexes
- Timeline
- 1991 – 2034
Study locations (20)
- Phoenix Children's Hospital- Site Number : 840003, Phoenix, Arizona, United States
- University of Arizona- Site Number : 840015, Tucson, Arizona, United States
- Arkansas Childrens Hospital- Site Number : 840109, Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences- Site Number : 840113, Little Rock, Arkansas, United States
- Tower Hematology/Oncology Medical Group- Site Number : 840056, Beverly Hills, California, United States
- University of California at Irvine- Site Number : 840036, Irvine, California, United States
- Southern California Permanente Medical Group- Site Number : 840108, Los Angeles, California, United States
- USC Health Sciences Center Dept of Genetics- Site Number : 840082, Los Angeles, California, United States
- Children's Hospital of Orange County- Site Number : 840074, Orange, California, United States
- Stanford Unviersity MC Dept of Genetics- Site Number : 840022, Palo Alto, California, United States
- UC Davis MIND Institute- Site Number : 840010, Sacramento, California, United States
- Kaiser Permanente Hospital- Site Number : 840042, Sacramento, California, United States
- University of California at San Diego- Site Number : 840007, San Diego, California, United States
- University of California at San Francisco- Site Number : 840051, San Francisco, California, United States
- Yale - Site Number : 840047, New Haven, Connecticut, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00358943 on ClinicalTrials.govOther trials for Gaucher disease
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT06528080A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher DiseaseShanghai Jiao Tong University School of Medicine
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06545136Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2)Spur Therapeutics
- ACTIVE NOT RECRUITINGNCT06488261Long Term Follow-Up for Safety of AVR-RD-02John Bernat
- RECRUITINGNANCT05992532GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple MyelomaFundación Española de Hematología y Hemoterapía
- RECRUITINGNANCT05843552Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher DiseaseUniversity of Minnesota
- RECRUITINGEARLY PHASE1NCT06272149An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher DiseaseXinhua Hospital, Shanghai Jiao Tong University School of Medicine
- RECRUITINGPHASE1NCT05487599A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)Prevail Therapeutics
- ACTIVE NOT RECRUITINGNCT05526664Omics Gaucher Study: Multiomic ApproachCENTOGENE GmbH Rostock